BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 38172945)

  • 41. Cancer immunotherapy using checkpoint blockade.
    Ribas A; Wolchok JD
    Science; 2018 Mar; 359(6382):1350-1355. PubMed ID: 29567705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The paradoxical role of tumor-infiltrating immune cells in lung cancer.
    Zheng X; Hu Y; Yao C
    Intractable Rare Dis Res; 2017 Nov; 6(4):234-241. PubMed ID: 29259850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement Activation via a C3a Receptor Pathway Alters CD4
    Kwak JW; Laskowski J; Li HY; McSharry MV; Sippel TR; Bullock BL; Johnson AM; Poczobutt JM; Neuwelt AJ; Malkoski SP; Weiser-Evans MC; Lambris JD; Clambey ET; Thurman JM; Nemenoff RA
    Cancer Res; 2018 Jan; 78(1):143-156. PubMed ID: 29118090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.
    Li T; Fan J; Wang B; Traugh N; Chen Q; Liu JS; Li B; Liu XS
    Cancer Res; 2017 Nov; 77(21):e108-e110. PubMed ID: 29092952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
    Hou GX; Liu P; Yang J; Wen S
    PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma.
    Brennan RC; Qaddoumi I; Mao S; Wu J; Billups CA; Stewart CF; Hoehn ME; Rodriguez-Galindo C; Wilson MW
    J Clin Oncol; 2017 Jan; 35(1):72-77. PubMed ID: 28034080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrent genetic defects in classical Hodgkin lymphoma cell lines.
    Hudnall SD; Meng H; Lozovatsky L; Li P; Strout M; Kleinstein SH
    Leuk Lymphoma; 2016 Dec; 57(12):2890-2900. PubMed ID: 27121023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical Models.
    Zhang L; Marrano P; Wu B; Kumar S; Thorner P; Baruchel S
    Clin Cancer Res; 2016 Jun; 22(11):2697-708. PubMed ID: 26719428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors.
    Mazor T; Pankov A; Johnson BE; Hong C; Hamilton EG; Bell RJA; Smirnov IV; Reis GF; Phillips JJ; Barnes MJ; Idbaih A; Alentorn A; Kloezeman JJ; Lamfers MLM; Bollen AW; Taylor BS; Molinaro AM; Olshen AB; Chang SM; Song JS; Costello JF
    Cancer Cell; 2015 Sep; 28(3):307-317. PubMed ID: 26373278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. jvenn: an interactive Venn diagram viewer.
    Bardou P; Mariette J; EscudiƩ F; Djemiel C; Klopp C
    BMC Bioinformatics; 2014 Aug; 15(1):293. PubMed ID: 25176396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-SMC condensin I complex, subunit D2 gene polymorphisms are associated with Parkinson's disease: a Han Chinese study.
    Zhang P; Liu L; Huang J; Shao L; Wang H; Xiong N; Wang T
    Genome; 2014 May; 57(5):253-7. PubMed ID: 25166511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-small-cell lung cancers: a heterogeneous set of diseases.
    Chen Z; Fillmore CM; Hammerman PS; Kim CF; Wong KK
    Nat Rev Cancer; 2014 Aug; 14(8):535-46. PubMed ID: 25056707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microenvironmental regulation of tumor progression and metastasis.
    Quail DF; Joyce JA
    Nat Med; 2013 Nov; 19(11):1423-37. PubMed ID: 24202395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The causes and consequences of genetic heterogeneity in cancer evolution.
    Burrell RA; McGranahan N; Bartek J; Swanton C
    Nature; 2013 Sep; 501(7467):338-45. PubMed ID: 24048066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
    Gao J; Aksoy BA; Dogrusoz U; Dresdner G; Gross B; Sumer SO; Sun Y; Jacobsen A; Sinha R; Larsson E; Cerami E; Sander C; Schultz N
    Sci Signal; 2013 Apr; 6(269):pl1. PubMed ID: 23550210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells.
    Polanska UM; Orimo A
    J Cell Physiol; 2013 Aug; 228(8):1651-7. PubMed ID: 23460038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
    Huang da W; Sherman BT; Lempicki RA
    Nat Protoc; 2009; 4(1):44-57. PubMed ID: 19131956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.
    Ben-Porath I; Thomson MW; Carey VJ; Ge R; Bell GW; Regev A; Weinberg RA
    Nat Genet; 2008 May; 40(5):499-507. PubMed ID: 18443585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
    Orimo A; Gupta PB; Sgroi DC; Arenzana-Seisdedos F; Delaunay T; Naeem R; Carey VJ; Richardson AL; Weinberg RA
    Cell; 2005 May; 121(3):335-48. PubMed ID: 15882617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a chromosome-targeting domain in the human condensin subunit CNAP1/hCAP-D2/Eg7.
    Ball AR; Schmiesing JA; Zhou C; Gregson HC; Okada Y; Doi T; Yokomori K
    Mol Cell Biol; 2002 Aug; 22(16):5769-81. PubMed ID: 12138188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.